Biblio
Export 793 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is V [Clear All Filters]
“A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
, “Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?”, J Alzheimers Dis, vol. 65, no. 1, pp. 89-97, 2018.
, “Cardiorespiratory Fitness and Cognitive Function are Positively Related Among Participants with Mild and Subjective Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1865-1875, 2018.
, “Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.”, J Alzheimers Dis, vol. 63, no. 1, pp. 103-114, 2018.
, “Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.”, J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
, “Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1519-1528, 2018.
, “Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 137-145, 2018.
, “Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
, “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
, “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
, “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
, “Crosstalk between Peripheral Small Vessel Properties and Anxious-like Profiles: Sex, Genotype, and Interaction Effects in Mice with Normal Aging and 3×Tg-AD mice at Advanced Stages of Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1531-1538, 2018.
, “Delirium Severity Post-Surgery and its Relationship with Long-Term Cognitive Decline in a Cohort of Patients without Dementia.”, J Alzheimers Dis, vol. 61, no. 1, pp. 347-358, 2018.
, “Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 239-253, 2018.
, “Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 897-915, 2018.
, “Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 61, no. 1, pp. 209-219, 2018.
, “Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 61, no. 1, pp. 209-219, 2018.
, “Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1307-1324, 2018.
, “Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 631-642, 2018.
, “Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.”, J Alzheimers Dis, vol. 65, no. 1, pp. 147-163, 2018.
, “Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.”, J Alzheimers Dis, vol. 64, no. 3, pp. 889-897, 2018.
, “Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?”, J Alzheimers Dis, vol. 61, no. 2, pp. 515-519, 2018.
, “Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1105-1116, 2018.
, “Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
, “Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.”, J Alzheimers Dis, vol. 64, no. 1, pp. 71-78, 2018.
,